Home Tags Alzheimer’s Disease

Alzheimer’s Disease Related Content

Alzheimer’s Disease is the most common cause of dementia. Dementia describing a specific set of symptoms such as memory loss, difficulties with problem-solving, language or simply thinking. As the disease progresses, proteins build up in the brain to form structures called ‘plaques’. Eventually there is a break between the nerve cells resulting the death of the cells and a loss of brain tissue. ending in a lack of motor skills. Although progression can vary, typically after diagnosis life expectancy is around three to nine years. Fewer than 3% of people live more than fourteen years.

Management

Medications, psychological intervention and care-giving are all available to AD patients. there are currently 5 different medications on offer for AD each have different results and side affects.

ArrestAD

ArrestAD: Exploiting the bittersweet side of Alzheimer’s disease

The Alzheimer’s disease puzzle is being completed. This is where the ArrestAD programme comes in, to exploit the bittersweet side of AD.
Alzheimer’s, mild cognitive impairment

Digital biomarker predicts mild cognitive impairment conversion to Alzheimer’s

Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
older people with dementia, bluetooth tracking device

A Bluetooth tracking device to aid the search for older people with dementia who...

Getting lost can affect caregivers and families of older people with dementia – now, a Bluetooth tracking device can assist the search for their loved ones.
preclinical alzheimer's disease, novel marker

Searching for a novel marker of preclinical Alzheimer’s disease

Research suggests that multisensory integration could be used as a novel marker for preclinical Alzheimer’s disease given reported associations between magnitude of visual-somatosensory integration and important cognitive and motor outcomes.
breakthroughs in dementia research

What we need to make breakthroughs in dementia research

David Thomas, Head of Policy (Access and Innovation) at Alzheimer’s Research UK, looks at what we need to make breakthroughs in dementia research.
brain disease

Three rare brain diseases that attack your language skills

According to NorthWestern Medicine, there are three different brain diseases that attack the language areas in the left hemisphere of the brain.
late-onset alcohol abuse

Late-onset alcohol abuse can be symptom of dementia

According to new results in the Journal of Alzheimer’s Disease, patients who start abusing alcohol in later life – after age 40 – maybe doing so due to underlying dementia
dementia day care, dementia day care

The importance of dementia day care services during COVID-19

Professor Timothy Kwok, Director of the Jockey Club Centre for Positive Ageing, and Research Manager Ms Bel Wong, explain the necessity of dementia day care services during the pandemic.
amyloid, membrane channels structures

Amyloid oligomer & membrane channel structures

H. Robert Guy, CEO from Amyloid Research Consultants, ascertains why amyloid oligomer & membrane channels structures can & must be determined.
indigenous communities dementia, Tsimane and moseten

Lowest global rates of dementia in Indigenous communities

The healthier pre-industrial lifestyles which Indigenous communities live by present solutions in preventing Alzheimer’s and dementia ­– as seen in their lower rates of the disease.
dementia covid-19, alzheimer's

How to help someone living with dementia understand the COVID-19 pandemic

Kym Ward, Dementia Project Coordinator at The Brain Charity, offers insight into how to support those living with dementia during times of uncertainty and isolation.
cognitive decline alzheimers

What is the reason for cognitive decline in Alzheimer’s disease?

New tech has helped confirm that the destruction of brain synapses underlies the cognitive deficits experienced by patients with Alzheimer’s
neurophysiological differences

What happens to our brains when we multitask?

The Del Monte Institute for Neuroscience have been shedding light on how health brains are able to multitask while walking
chronic stress

$2 million grant to explore link between chronic stress and Alzheimer’s

Researchers at WVA are investigating the connection between chronic stress and Alzheimer’s Disease using new $2 million grant from NIH
healthy cognition

Protecting ageing synapses through exercise

Keeping the ageing population as active as possible, enhances the connections between neurons to maintain healthy cognition.
Epilepsy and alzheimer's

Alzheimer’s: A disease not just about memory loss

Head of Research Dr Sara Imarisio brings to light emerging research on the link between epilepsy and Alzheimer’s disease
project alzheimer's

Preparing for the next pandemic: Alzheimer’s disease

Alzheimer’s disease, a growing silent pandemic, is discussed here by Project Alzheimer’s Value Europe (PAVE), who introduce their stakeholder forum that focuses on developing new research in the field, such as emerging therapeutic & diagnostic innovations.
vaccine for Alzheimer’s

Scientists develop new potential vaccine for Alzheimer’s

A new potential treatment and vaccine for Alzheimer’s disease has been developed by a team of UK and German scientists, using a different approach with amyloid beta protein.
dementia cases

What do rising dementia cases after the pandemic mean for local government?

John Ramsay, Founder and Managing Director of Social-Ability, discusses what rising dementia cases mean for local authorities and social care spending.
gene severe covid, alzheimers

Scientists identify gene linking severe COVID and Alzheimer’s

A new study has uncovered a gene that links severe COVID and Alzheimer's, via "immune system changes" that can happen in both conditions.

Follow Open Access Government